Journal
TRENDS IN MOLECULAR MEDICINE
Volume 15, Issue 12, Pages 580-591Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2009.10.005
Keywords
-
Funding
- Association Francaise contre les Myopathies (AFM)
Ask authors/readers for more resources
Although most molecular therapy strategies for genetic diseases are based on gene replacement, interesting alternative approaches target RNA. These strategies rely on the modification of the mutated gene's expression in vivo by modulating pre-mRNA splicing, mRNA stability or mRNA translation. Here, we review recent progress using these RNA-based approaches in the field of muscle and muscle-related genetic diseases. Different molecular tools, including modified antisense oligonucleotides, pre-mRNA trans-splicing molecules, ribozymes or chemical compounds have been used successfully on patient cells or animal models of disease. These diverse strategies show tremendous therapeutic potential and several clinical trials have been initiated with Duchenne muscular dystrophy patients with promising results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available